Resolving Common Capsule Manufacturing Defects: Shell Leakage, Weight Variation, and Splits

Resolving Common Capsule Manufacturing Defects: Shell Leakage, Weight Variation, and Splits

Published on 27/12/2025

Further reading: Capsule Manufacturing Defects

How to Troubleshoot Capsule Manufacturing Defects in Pharmaceutical Production

Capsules remain one of the most preferred solid oral dosage forms due to their ease of swallowing, flexibility in formulation, and aesthetic appeal. However, manufacturing capsules—especially hard gelatin or HPMC capsules—is not without challenges. Common defects such as shell leakage, weight variation, splitting, and brittleness can lead to regulatory issues, batch rejections, and consumer complaints. This tutorial-style guide helps pharmaceutical professionals understand the causes of capsule defects and offers practical solutions for achieving defect-free production.

What Are Capsule Manufacturing Defects?

Capsule defects refer to undesirable physical, mechanical, or functional attributes observed during manufacturing or inspection. These can compromise product integrity, dosage accuracy, or patient safety. Key defects include:

  • Shell Leakage – contents leak from either end of the capsule due to improper closure or cracks
  • Weight Variation – inconsistent capsule fill weights across the batch
  • Capsule Splitting or Cracking – shell breaks during filling, transport, or storage
  • Denting or Deformation – loss of capsule shape due to high compression or moisture
  • Empty Capsules – capsules with no fill due to machine misfeed or poor blend flow

These issues impact content uniformity, stability, and patient compliance. They are often

associated with formulation behavior, equipment calibration, capsule shell quality, or environmental conditions.

Pharma Tip:  Capsule fill weight variability during inspection prep – regulatory inspection finding risk

Explore the full topic: Manufacturing Defects

Common Causes of Capsule Defects

1. Shell Leakage

This defect usually stems from poor locking of capsule cap and body, often due to improper alignment, damaged shells, or low moisture content. In hard gelatin capsules, over-dried shells can become brittle, leading to microscopic cracks.

2. Weight Variation

Inconsistent fill weights are often due to poor flow properties of the powder blend, feeder block misalignment, tamping pin variation, or static build-up. Segregation in the hopper can worsen this problem during long runs.

3. Shell Splits and Cracks

Capsules crack when subjected to excessive force during dosing, poorly adjusted dosing disc, or sharp-edged machine components. High-speed capsule filling machines amplify this risk.

4. Denting or Deformation

This happens during capsule loading, packaging, or post-filling drying. Excessive vacuum, poorly calibrated capsule transport mechanisms, or external compression in blisters are common causes.

5. Empty or Partially Filled Capsules

They result from intermittent feed issues, powder bridging, erratic flow, or mechanical wear in the filling turret. It’s a frequent issue in high-speed production where minor delays cause cumulative fill errors.

To avoid these issues, adhere strictly to in-process controls, equipment checks, and environmental monitoring protocols. Refer to pharmaceutical SOP templates for capsule filling and inspection procedures.

Regulatory Expectations and GMP Guidance

Capsule manufacturing must align with global GMPs. As per CDSCO and USFDA standards:

  • 21 CFR Part 211.110 requires in-process control for uniformity of dosage units
  • EU GMP Annex 1 & 15 mandate visual inspection and equipment validation
  • WHO Technical Report Series 986 outlines capsule shell quality checks and storage requirements
Pharma Tip:  Cross-contamination detected during inspection prep – manufacturing vs material root cause

Any deviation related to capsule fill weight, physical integrity, or shell defects must be thoroughly documented with root cause and corrective action. Manufacturers must also qualify the equipment used for capsule filling, sealing, and inspection as per validation protocols.

Best Practices to Minimize Capsule Defects

Here are proven strategies for reducing capsule manufacturing defects:

  1. Maintain Shell Moisture: Store capsules at 20–25°C and 40–60% RH. Over-dried shells become brittle and crack easily. Use dehumidifiers or RH-controlled rooms when needed.
  2. Optimize Blend Properties: Ensure good flow by using suitable excipients (e.g., colloidal silica). Sieve appropriately and use glidants for powder blends with poor flow.
  3. Machine Calibration: Check alignment, fill weight, vacuum, and closing pressures. Regularly clean the dosing disc, tamping pins, and ejection pins.
  4. Tooling Maintenance: Replace worn-out segments and polish surfaces that contact the capsule. Ensure no rough edges exist that could tear shells.
  5. Control Environmental Factors: High humidity causes gelatin to soften, while dry conditions make capsules brittle. Install sensors to monitor conditions continuously.
  6. Inspect Capsule Shells: Reject capsules with visual abnormalities—dents, deformation, or dullness. Avoid using aged stock without checking integrity.
  7. Implement IPC Checks: In-process checks for weight variation, locking, visual defects, and shell integrity help identify problems early.
Pharma Tip:  Capsule locking failure after supplier change – CAPA inadequacy explained

Establish these in a documented GMP compliance plan and review regularly for effectiveness.

Case Study: Solving Shell Leakage in Gelatin Capsules

A mid-size pharma company reported leakage from filled hard gelatin capsules packed in blisters. Investigation showed that RH in the filling area dropped below 30%, making capsules brittle. The brittle cap cracked during sealing. CAPA included maintaining RH at 45%, upgrading HVAC sensors, and sourcing shells with higher bloom strength. Subsequent batches showed zero leakage, and blisters passed stability testing at accelerated conditions.

Documentation and Training

Quality documentation must include batch-wise defect logs, root cause analysis reports, and trends in capsule rejection. Personnel must be trained in detecting and categorizing capsule issues during operation and post-filling inspection.

  • Record deviations and link to preventive actions
  • Maintain capsule shell COAs from suppliers
  • Implement capsule-specific cleaning validation procedures for machine changeovers

Training programs should include hands-on equipment use, capsule visual defect library, and interactive troubleshooting sessions. Refer to pharma regulatory training guidelines for audit-readiness modules.

Conclusion

Capsule manufacturing defects like shell leakage, weight variation, and splitting pose quality and compliance risks. By optimizing blend properties, machine calibration, environmental controls, and personnel training, manufacturers can significantly reduce these issues. Implementing structured SOPs, real-time monitoring, and thorough root cause analysis ensures a robust encapsulation process that consistently delivers quality products.

Explore more on clinical trial capsule usage and how packaging integrity impacts dosage adherence in study settings.

Also Read